Food & Drug Administration (FDA)

From FDA to MHRA: are drug regulators for hire?

This article by Maryanne Demasi has been published in the British Medical Journal: “Patients and doctors expect drug regulators to provide an unbiased, rigorous assessment of investigational medicines before they hit the market. But do they have sufficient independence from the companies…
Read more

The Emperor’s New Drugs : Antidepressants and the Placebo Effect

This free course (from Mad in America Continuing Education) includes a lecture video from Prof. Irving Kirsch (Associate Director of the Program in Placebo Studies and lecturer in medicine at the Harvard Medical School and Beth Israel Deaconess Medical Center), together with…
Read more

Prophylactic effects or withdrawal reactions? An analysis of time-to-event data from antidepressant relapse prevention trials submitted to the FDA

Prof. Peter Gøtzsche has tweeted : “When you stop taking a depression pill and feel bad, psychiatrists tell you that you have relapsed. Not so. By far most, perhaps even all your troubles, are withdrawal symptoms … Never stop abruptly. This…
Read more

What doctors don’t know about the drugs they prescribe

TED Talk (13 minute video) … The video’s producers say: “When a new drug gets tested, the results of the trials should be published for the rest of the medical world — except much of the time, negative or inconclusive…
Read more

Follow

Get the latest posts delivered to your mailbox:

Your email address will not be passed to any other organisation. It will only be used to send you new posts made on this website.

MENU